Celularity Reports Second-Quarter Revenue of $5.43M, Diluted EPS of $0.02
Celularity reported second-quarter 2026 revenue of $5.43 million and net income attributable to common shareholders of $0.55 million, or diluted EPS of $0.02. Revenue was $5.74 million and the company reported a loss in the year-ago quarter.